192
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Mortality in A Cohort of Radiation Treated Childhood Skin Hemangiomas

, &
Pages 789-794 | Accepted 30 Dec 1988, Published online: 08 Jul 2009
 

Abstract

Mortality was studied in 18357 patients (33% males and 67% females) with skin hemangioma admitted to Radiumhemmet between 1920 and 1959. the treatments of the hemangiomas were performed by radium-226 sources (13094 patients) or x-ray therapy (2540 patients). in 2723 patients no radiotherapy was given. the median age was 6 months for the treated patients and 8 months for the patients not receiving radiotherapy. Between 1920 and 1951 a total of 154 patients were reported dead. the cohort was matched with the Swedish Cause of Death Register between 1952 and 1985. During that period 504 died, in 146 patients the cause of death was cancer or leukemia. the total number of person-years at risk was 587426. in patients treated with radium-226 or orthovoltage x-rays, 410 deaths occurred (standardized mortality ratio (SMR) = 1.07; ns). in patients given contact therapy 34 deaths occurred (SMR=0.82; ns) and in the not irradiated group 60 deaths occurred (SMR=0.78; ns). Patients treated with radium-226 or orthovoltage x-rays had an SMR of 1.34 for all cancers combined (p<0.05). for patients treated between 1920 and 1939 the SMR for cancer was 1.53 (p<0.05) as compared to an SMR of 1.16 (ns) for those treated between 1940 and 1959.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.